Nuclear Medicine: Page 77

Start-up to develop arthritis molecular imaging agent

By AuntMinnie.com staff writers

U.K. life sciences developer Serac Life Sciences has established a new company, Serac Healthcare, to develop a molecular imaging agent that will help rheumatologists manage treatment for their arthritis patients.

June 27, 2018

SNMMI: AI enables stress-first SPECT MPI protocol

By Erik L. Ridley

PHILADELPHIA - Artificial intelligence (AI) analysis of stress SPECT myocardial perfusion imaging (MPI) can be highly sensitive for all types of coronary artery disease, according to research presented Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 26, 2018

Live from SNMMI 2018: Update on radiopharmaceuticals

What's going on in the world of medical isotopes? From molybdenum supply to reimbursement, there is no lack of issues facing the Council for Radionuclides and Radiopharmaceuticals (CORAR). Michael Guastella, CORAR’s executive director, spoke with AuntMinnie.com Features Editor Wayne Forrest during the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 26, 2018

SNMMI: Theranostic agent awarded Image of the Year

By Wayne Forrest

PHILADELPHIA - A PET image that shows the combined power of the diagnostic and therapeutic (theranostic) use of molecular imaging to identify and treat metastatic castration-resistant prostate cancer has been named this year's Image of the Year at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 26, 2018

Live from SNMMI 2018: Nuclear medicine and patients

Patients justifiably are the centers of attention in imaging procedures, and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) is reaching out to them through the formation of a patient advocacy advisory board. In this video from SNMMI 2018, AuntMinnie.com Features Editor Wayne Forrest speaks with Josh Mailman, inaugural chair of the board.

June 26, 2018

SNMMI: Cerebrovascular risk tied to Alzheimer's disease

By Wayne Forrest

PHILADELPHIA - A study on amyloid plaque accumulation, white-matter hyperintensity, and cortical thickness has found that a patient's cerebrovascular characteristics should be considered for their potential effect on the progression of Alzheimer's disease. The findings were presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 26, 2018

SNMMI: Early prostate cancer therapy extends lives

By Erik L. Ridley

PHILADELPHIA - Providing lutetium-177 prostate-specific membrane antigen radioligand therapy earlier to patients with metastatic prostate cancer can extend lives, according to research presented on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.

June 26, 2018

SNMMI: Fluciclovine-PET changes prostate treatment

By Wayne Forrest

PHILADELPHIA - With the addition of F-18 fluciclovine to PET/CT scans, clinicians changed the treatment regimen for a majority of men with recurrent prostate cancer and located previously undetected lesions in a new study, which was presented on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.

June 25, 2018

FluoroPharma, Ground Fluor partner on MFBG agent

By AuntMinnie.com staff writers

Radiopharmaceutical developer FluoroPharma Medical has acquired an exclusive option to license the meta-fluorobenzylguanidine (MFBG) imaging agent from Ground Fluor Pharmaceuticals.

June 25, 2018

SNMMI: Molecular imaging method monitors gene therapy

By AuntMinnie.com staff writers

PHILADELPHIA - A new molecular imaging method can monitor the level and location of gene expression everywhere in the brain, enabling early assessment of gene therapy for brain disease, according to findings presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.

June 25, 2018

Live from SNMMI 2018: Nuclear medicine appropriate use

What's the best way to promote appropriate use of nuclear medicine? Dr. Sukhjeet Ahuja, director of evidence and quality at the Society of Nuclear Medicine and Molecular Imaging (SNMMI), spoke with Features Editor Wayne Forrest during this week’s SNMMI annual meeting about how appropriate use criteria are developed and how clinicians should proceed.

June 24, 2018

Live from SNMMI 2018: Securing the molybdenum supply

Global efforts are underway to ensure that adequate supplies of molybdenum-99 can match demand for nuclear medicine scans. Jim Harvey, PhD, of NorthStar Medical Radioisotopes spoke with Features Editor Wayne Forrest during this week’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting about the worldwide collaborative initiative.

June 24, 2018

Previous Page

Page 77 of 440

Next Page